See Change® in Protein Characterization
University of Washington: Characterization of β-amyloid oligomers
Valerie Daggett, Professor of Bioengineering (primary), Biochemistry, Biomedical and Health Informatics, Chemical Engineering, Molecular Engineering, Neuroscience, and Biological Physics, Structure and Design
"We believe it [AQS3pro] can play a significant role in the protein characterization technology toolkit, overcoming shortcomings in existing techniques."
Next Generation in Protein Characterization
The AQS3pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS3pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS3delta Analytical Software package, it streamlines and simplifies 5 key measurements:
Aggregation | Quantitation | Stability | Structure | Similarity
See change in your protein, in your workflow, and in your efficiency.
Visit the product page to learn more.
Latest News
RedShiftBio Expands Commercial Team to Support Demand for AQS3proTM
RedShiftBio’s AQS3pro Changes the Game in the Detection and Treatment of Alzheimer’s
RedShiftBio Shipping AQS3pro as Industry Endorsements Expand
Photonics Media publishes article on Technological Synergies Move Spectroscopy Out of the Lab
Well Characterized Biologics & Biological Assays, Nov 11-13, Reston, VA
MIBio Conference, Nov 13, Cambridge UK
PEGS Europe, Nov 18-22, Lisbon
RedShiftBio®
RedShiftBio® is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.
Awards
Contact Us
RedShift BioAnalytics Inc.
131 Middlesex Turnpike
Burlington, MA 01803
T: 781.345.7300
F: 781-345-7301
E: info@redshiftbio.com
RedShift™, RedShiftBio®, See Change®, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.